Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Poster - PhysicianPharm

  • You have access
    Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans.
    Khushboo Gupta, Rahul Jadhav, Jagadeseh Singh and Rameshwar Prasad
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1005;
  • You have access
    Diagnostic Efficacy of Quantitative Indexes on [99mTc]DPD SPECT/CT for Cardiac Amyloidosis: Inter-Observer Agreement and Association with Conventional Scoring
    Sungwoo Bae, Joonhyung Gil, Jin Chul Paeng, Hongyoon Choi, Keon Wook Kang, Gi Jeong Cheon and Dong Soo Lee
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1670;
  • You have access
    The Effect of BMI on High versus Low Administered Activity Protocol MPI Scan Time Using a CZT Camera in Clinical Practice
    Kalpna Prasad, Chad Adams, Eiping Quang and Derek Stocker
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1643;
  • You have access
    Comparative analysis of multi-modality cardiac imaging for prediction of postoperative myocardial infarction
    Wanwan Wen, Mingxin Gao, Jingjing Meng, Yujie Bai, Xiang Li and Xiaoli Zhang
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1665;
  • You have access
    Application of 18F-FDG PET/CT in early detection of therapy-associated cardiotoxicity in patients with lymphoma.
    Mao Mao Wei and Xuejuan Wang
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1667;
  • You have access
    The Role of 18F-FDG-PET/CT Imaging in Predicting Outcome of Patients with Newly Diagnosed Multiple Myeloma
    Esther Mena, Maria Liza Lindenberg, Ismail Turkbey, Stephen Adler, Philip Eclarinal, Yolanda McKinney, Juanita Weaver, Peter Choyke and Dickran Kazandjian
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1678;
  • You have access
    PET imaging of arterial inflammation in people living with HIV infection: A comparison between [68Ga]Ga-Pentixafor and 18F-FDG
    Ismaheel Lawal, Kgomotso Mokoala, Gbenga Popoola, Honest Ndlovu, Letjie Maserumule, Jens Kaufmann, Hakim Bouterfa, Hans Wester, Jan Rijn Zeevaart and Machaba Sathekge
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1660;
  • You have access
    A clinical study of baseline PET/CT parameters in the prediction of refractory/ relapsed diffuse large B cell lymphoma of advanced stage patients
    Hebei Li and Qian Wang
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1685;
  • You have access
    Low Incidence Rates of Mucositis, Febrile Neutropenia or Sepsis in the Prospective, Randomized Phase 3 Sierra Trial for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Targeted Delivery of Anti-CD45 Iodine (131I) Apamistamab [Iomab-B]
    Mona Natwa, Susan Passalaqua, Ming-Kai Chen, Robert Wagner, Wendell Yap, Landis Griffeth, Gregory Wiseman, Joyce Mhlanga, Richard Wahl, Norbert Avril, Robert Hellman, Dominick Lamonica, Manuela Matesan, Beth Chasen, Neil Hansen, Eugene Leung, Joseph Osborne, Jennifer Peterson, Yusuf Menda, Dinko Franceschi, Qing Liang, Vijay Reddy, Mark Berger and Neeta Pandit-Taskar
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1694;
  • You have access
    Prediction of Treatment Outcome and Survival Using 18F-FDG PET/CT Radiomic Features and Standard Biomarkers in Patients with Advanced Melanoma Treated Using Dual Immune Checkpoint Inhibitor Therapy
    John Crandall, Noah Wasserman and Richard Wahl
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1704;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 66
SNMMI

© 2025 SNMMI

Powered by HighWire